You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
|
|---|---|
| Published in |
Annals of Clinical Microbiology and Antimicrobials, May 2009
|
| DOI | 10.1186/1476-0711-8-18 |
| Pubmed ID | |
| Authors |
Luigi Principe, Silvia D'Arezzo, Alessandro Capone, Nicola Petrosillo, Paolo Visca |
| Abstract |
Infections sustained by multidrug-resistant (MDR) and pan-resistant Acinetobacter baumannii have become a challenging problem in Intensive Care Units. Tigecycline provided new hope for the treatment of MDR A. baumannii infections, but isolates showing reduced susceptibility have emerged in many countries, further limiting the therapeutic options. Empirical combination therapy has become a common practice to treat patients infected with MDR A. baumannii, in spite of the limited microbiological and clinical evidence supporting its efficacy. Here, the in vitro interaction of tigecycline with seven commonly used anti-Acinetobacter drugs has been assessed. |
Mendeley readers
The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | 1% |
| Ecuador | 1 | 1% |
| Kenya | 1 | 1% |
| South Africa | 1 | 1% |
| Canada | 1 | 1% |
| Unknown | 84 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 16% |
| Student > Ph. D. Student | 12 | 13% |
| Student > Master | 11 | 12% |
| Student > Postgraduate | 10 | 11% |
| Other | 10 | 11% |
| Other | 18 | 20% |
| Unknown | 14 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 29% |
| Agricultural and Biological Sciences | 16 | 18% |
| Biochemistry, Genetics and Molecular Biology | 8 | 9% |
| Immunology and Microbiology | 6 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
| Other | 13 | 15% |
| Unknown | 15 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2012.
All research outputs
#20,178,948
of 22,693,205 outputs
Outputs from Annals of Clinical Microbiology and Antimicrobials
#533
of 605 outputs
Outputs of similar age
#93,082
of 96,926 outputs
Outputs of similar age from Annals of Clinical Microbiology and Antimicrobials
#2
of 2 outputs
Altmetric has tracked 22,693,205 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 605 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,926 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.